5:46 PM
 | 
May 27, 2008
 |  BC Extra  |  Company News

Intas to launch generic gefitinib in India

Intas (Ahmedabad, India) said it plans to launch a generic version of gefitinib in India to treat lung cancer under the brand name Geffy. AstraZeneca (LSE:AZN; NYSE:AZN) markets Iressa gefitinib in 36...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >